Wilmington Funds Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Wilmington Funds Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$201K	Hold	3,254	–	–	0.02%	676
2014 Q1	$212K	Sell	3,254 -440	-12%	-$29.8K	0.02%	665
2013 Q4	$208K	Sell	3,694 -411	-10%	-$23.1K	0.02%	703
2013 Q3	$252K	Hold	4,105	–	–	0.02%	617
2013 Q2	$240K	Buy	+4,105	New	+$253K	0.02%	596

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wilmington Funds Management's OREX Position: Q2 2014 in Review

Wilmington Funds Management held its Orexigen Therapeutics, Inc. (OREX) position steady in Q2 2014 at 3,254 shares worth $201K. The position accounts for 0.02% of the portfolio, ranked #676.

Wilmington Funds Management first reported a position in OREX in Q2 2013 and has held it in 5 quarters since. The position peaked at $252K in Q3 2013. 129 funds tracked by Wall St. Rank hold OREX as of Q2 2014.

Wilmington Funds Management held 3,254 shares of Orexigen Therapeutics, Inc. worth $201K as of Q2 2014.
Wilmington Funds Management left its Orexigen Therapeutics, Inc. share count unchanged in Q2 2014.
Orexigen Therapeutics, Inc. made up 0.02% of Wilmington Funds Management's portfolio in Q2 2014, its #676 holding.
Wilmington Funds Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and has held it in 5 quarters since.
Wilmington Funds Management's Orexigen Therapeutics, Inc. position peaked at $252K in Q3 2013.
129 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.